Serum omentin-1 as a disease activity marker for crohn's disease

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Lu, Yan ^a   Zhou, Li ^b   Liu, Lifeng ^a   Feng, Yan ^c   Lu, Li ^d   Ren, Xiaoyan ^a   Dong, Xinqian ^a   Sang, Weiwei ^a  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b Second People s Hospital of Liaocheng   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

^d Liaocheng International Peace Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; OMENTIN 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ACTIVITY; DISEASE MARKER; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REMISSION; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING; ADULT; BLOOD; CASE CONTROL STUDY; COLON; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLON; CROHN DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84896967975     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/162517     Document Type: Article

References (18)

1. Cougard P. A., Desjeux A., Vitton V., Baumstarck-Barrau K., Lesavre N., Grimaud J. C., The usefulness of factor XIII levels in Crohn's disease. Journal of Crohn's and Colitis 2012 6 6 660 664 2-s2.0-83355170530 10.1016/j.crohns. 2011.11.016
2. Best W. R., Becktel J. M., Singleton J. W., Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979 77 4 843 846 2-s2.0-0018292707
3. Lahiff C., Safaie P., Awais A., The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2013 37 8 786 794
4. Lewis J. D., The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011 140 6 1817 1826 2-s2.0-79955555545 10.1053/j.gastro.2010.11.058
5. Schäffler A., Neumeier M., Herfarth H., Fürst A., Schölmerich J., Büchler C., Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochimica et Biophysica Acta 2005 1732 1-3 96 102
6. Tan B. K., Adya R., Randeva H. S., Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends in Cardiovascular Medicine 2010 20 5 143 148 2-s2.0-79960078829 10.1016/j.tcm.2010.12.002
7. de Souza Batista C. M., Yang R. Z., Lee M. J., Glynn N. M., Yu D. Z., Pray J., Ndubuizu K., Patil S., Schwartz A., Kligman M., Fried S. K., Gong D. W., Shuldiner A. R., Pollin T. I., McLenithan J. C., Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007 56 6 1655 1661 2-s2.0-34249674520 10.2337/db06-1506
8. Mahde A., Shaker M., Al-Mashhadani Z., Study of omentin1 and other adipokines and hormones in PCOS patients. Oman Medical Journal 2009 24 108 118
9. Yan P., Liu D., Long M., Ren Y., Pang J., Li R., Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes 2011 119 4 257 263 2-s2.0-79953816011 10.1055/s-0030-1269912
10. Zhong X., Zhang H. Y., Tan H., Zhou Y., Liu F. L., Chen F. Q., Shang D. Y., Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacologica Sinica 2011 32 7 873 878 2-s2.0-79960058232 10.1038/aps.2011.26
11. Yamawaki H., Kuramoto J., Kameshima S., Usui T., Okada M., Hara Y., Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochemical and Biophysical Research Communications 2011 408 2 339 343 2-s2.0-79955662090 10.1016/j.bbrc.2011.04.039
12. Lennard-Jones J. E., Classification of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 1989 24 170 2 6 2-s2.0-0024810567
13. Drossman D. A., Dumitrascu D. L., Rome III: new standard for functional gastrointestinal disorders. Journal of Gastrointestinal and Liver Diseases 2006 15 3 237 241 2-s2.0-33749256469
14. van de Logt F., Day A. S., S100A12: a noninvasive marker of inflammation in inflammatory bowel disease. Journal of Digestive Diseases 2013 14 2 62 67 10.1111/1751-2980.12012
15. Vermeire S., van Assche G., Rutgeerts P., C-reactive protein as a marker for inflammatory bowel disease. Inflammatory Bowel Diseases 2004 10 5 661 665 2-s2.0-4644313604 10.1097/00054725-200409000-00026
16. Kazama K., Usui T., Okada M., Hara Y., Yamawaki H., Omentin plays an anti-inflammatory role through inhibition of TNF-a-induced superoxide production in vascular smooth muscle cells. European Journal of Pharmacology 2012 686 1-3 116 123
17. Pan H. Y., Guo L., Li Q., Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Research and Clinical Practice 2010 88 1 29 33 2-s2.0-77649232845 10.1016/j.diabres.2010.01.013
18. Moreno-Navarrete J. M., Ortega F., Castro A., Sabater M., Ricart W., Fernández-Real J. M., Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity 2011 19 8 1552 1559 2-s2.0-79960841856 10.1038/oby.2010.351